GO
Loading...

Health Care Equipment and Supplies

More

  • In preparatory documents posted on the agency's website on Tuesday, FDA reviewers said laparoscopic power morcellator devices, which are used to treat uterine fibroids, allow for less invasive surgeries, shorter recovery time and fewer wound site infections.

  • FRANKFURT, July 1- German drugmaker Bayer said it would keep the Dr. Scholl's and Coppertone- each worth more than $1 billion- Bayer said it was not planning to untie the Merck bundle it secured in May in a competitive bidding tussle with Reckitt Benckiser, Procter& Gamble Co and Novartis.

  • FRANKFURT, July 1- German drugmaker Bayer said it would keep the Dr. Scholl's and Coppertone- each worth more than $1 billion- Bayer said it was not planning to untie the Merck bundle it secured in May in a competitive bidding tussle with Reckitt Benckiser, Procter& Gamble Co and Novartis.

  • AstraZeneca Chair: Shareholders, 'vote me away' Monday, 19 May 2014 | 11:14 AM ET

    As AstraZeneca's shares slid following its rejection of Pfizer's new bid, the company's chairman said he was "reasonably confident" it was the right decision.

  • J&J beats forecasts, helped by new medicines Tuesday, 15 Apr 2014 | 10:06 AM ET

    Johnson & Johnson turned in a solid first quarter Tuesday, topping analysts' profit and revenue estimates and increasing its 2014 earnings forecast by 5 cents a share.

  • Venture funds see growth in health care start-ups Sunday, 9 Mar 2014 | 1:17 PM ET

    As healthcare reform begins to take shape, venture capitalists see emerging opportunities in digital health start-ups.

  • Smile! Here's the next 'smart' product Thursday, 20 Feb 2014 | 10:00 AM ET

    P&G is bringing the dentist into your bathroom a smartphone-connected toothbrush, a device that gives personalized advice to help people improve their brushing.

  • Obamacare Inc: Allies urge White House to tap CEO Monday, 30 Dec 2013 | 7:28 AM ET

    The White House is coming under pressure from some of its closest allies to name a CEO to run its health insurance marketplace.

  • Icahn reports large stake in medical device maker Thursday, 21 Nov 2013 | 10:25 AM ET
    Carl Icahn, billionaire investor and chairman of Icahn Enterprises Holdings LP

    Activist investor Carl Icahn reported a 12.63 stake in medical device maker Hologic, prompting the company to seek protection from a hostile takeover

  • One man, one small business, four billionaires Wednesday, 13 Nov 2013 | 8:00 AM ET

    An entrepreneur has attracted investments from four billionaires: Sam Zell, Herb Simon, David Bonderman and "one family you've never heard of."

  • JNJ to pay $2.2 billion in US probe: Feds Monday, 4 Nov 2013 | 1:53 PM ET

    Johnson & Johnson and its subsidiaries were accused of promoting powerful psychiatric drugs for unapproved uses in children, seniors and disabled patients.

  • Prognosis: Healthy earnings for pharma, biotech Tuesday, 16 Jul 2013 | 5:46 PM ET
    A doctor checks a patient who is experiencing flu symptoms.

    Pharmaceutical and biotech stocks have outperformed markets this year, and with J&J's second-quarter earnings beat, investors may hope earnings will push stocks even higher.

  • Heart Device Approval Delays Leave Doctors Frustrated Monday, 27 May 2013 | 11:33 AM ET

    Americans accustomed to immediate access to the newest technology may be shocked to find that is not the case when it comes to devices that treat ailing hearts.

  • Keith Smith, Co-founder, Managing Partner at the Surgery Center of Oklahoma says that all funds are channeled to patient care, helping his team deliver quality healthcare and low costs.

  • Patients Scarred After Robotic Surgery Friday, 19 Apr 2013 | 8:58 AM ET
    Da Vinci Surgical robot designed to facilitate complex surgery using a minimally invasive approach.

    Most robotic surgery takes place without a hitch, but a growing number of complaints and lawsuits allege complications and even deaths from Intuitive Surgical's da Vinci device.

  • Marketing Is Key to Surgical Robot’s Success Thursday, 18 Apr 2013 | 8:14 PM ET

    If the critics of robotic surgery are right—that safety is an issue—how is that it was performed on 450,000 people last year? The answer may lie in one word: Marketing.

  • Counting the Problems of Robot-Assisted Surgery Thursday, 18 Apr 2013 | 7:58 PM ET
    Dr. Marty Makary of Johns Hopkins University Hospital

    The number of complications from robot-assisted surgery using Intuitive Surgical's da Vinci robot are underreported, allege critics of the procedure, fanning the controversy around the company's pioneering product.

  • Controversy Over Surgical Robotics Heats Up Thursday, 18 Apr 2013 | 5:05 PM ET
    A surgeon looks through the da Vinci surgical system's monitor.

    Intuitive Surgical's da Vinci robot was once hailed as a revolution in the operating room, but as more reports of complications have come to light, the da Vinci debate is heating up.

  • What Happens When the Surgical Robot Malfunctions? Tuesday, 19 Mar 2013 | 11:08 AM ET

    Like all computers, Intuitive Surgical's da Vinci robot can malfunction during surgery. A range of results have been reported by surgeons.

  • The Da Vinci Code: Growing Sales, Growing Concerns Tuesday, 19 Mar 2013 | 11:04 AM ET

    In recent years, as the surgical robot's popularity has grown, so have questions and concerns about its safety, training and the aggressiveness of its marketing.